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uring human placentation, fetal cytotrophoblast stem cells differentiate and then invade the uterine wall and its
ssociated spiral arteries. This process anchors the placenta to the uterus and supplies maternal blood to the fetus.
ytotrophoblast invasion in vitro requires the expression of matrix metalloproteinase-9 (MMP-9). Recently, we showed that
ytotrophoblasts produce interleukin-10 (IL-10), a potent immunomodulatory cytokine that could have paracrine effects on
he maternal immune system. IL-10 synthesis is dramatically downregulated after the first 12 h of culture, while MMP-9
ecretion is rapidly upregulated and the cells acquire an invasive phenotype. These observations prompted us to investigate
hether IL-10 is an autocrine regulator of cytotrophoblast MMP-9 production. We found that the cells expressed IL-10
eceptor mRNA, suggesting that autocrine effects are possible. Adding recombinant IL-10 to cytotrophoblast cultures
ignificantly decreased the cells’ MMP-9 expression at both protein and mRNA levels, but did not affect mRNA levels of the
issue inhibitor of metalloproteinase-3. Thus, IL-10 may alter the proteinase/inhibitor balance. IL-10 treatment further
aused a net decrease in MMP activity, thereby reducing cytotrophoblast invasiveness. An antibody that neutralized
ndogenous IL-10 function had the opposite effect in all experiments. Together, these data suggest that IL-10 is an autocrine
nhibitor of cytotrophoblast MMP-9 activity and invasiveness. © 1999 Academic PressKey Words: placenta; cytotrophoblast; IL-10; MMP-9; invasion.
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Successful formation of the human placenta requires the
correct differentiation of specialized fetal cells termed cy-
totrophoblasts (reviewed in Cross et al., 1994; Rinkenberger
t al., 1997). Cytotrophoblast stem cells are attached to an
xtensive basement membrane that surrounds the stromal
ore of two types of chorionic villi. In floating villi, cytotro-
hoblasts differentiate by fusing to form an overlying layer
f multinucleate syncytiotrophoblasts. These cells are in
ontact with maternal arterial blood that bathes the float-
ng villi. The primary function of the syncytium is to
erform nutrient, waste, and gas exchange between the
aternal and fetal circulations. In anchoring villi, a subset
1 To whom correspondence should be addressed at Department
of Stomatology, HSW 604, University of California–San Francisco,m
t
San Francisco, California 94143-0512. Fax: (415) 476-4204. E-mail:
sfisher@cgl.ucsf.edu.
194f cytotrophoblasts at the distal tips of the villi differentiate
y leaving their basement membrane and invading the
terus. These invasive cytotrophoblasts populate the de-
idualized endometrium and the first third of the myome-
rium, replacing the walls of uterine spiral arterioles in
hese regions (Brosens et al., 1978; Damsky et al., 1992).
This unusual process anchors the placenta to the uterus and
supplies the fetus with maternal blood. Cytotrophoblast
invasion must be tightly regulated because errors in the
depth of uterine penetration can have severe negative
effects on pregnancy outcome. Disorders such as pre-
eclampsia (Zhou et al., 1993) and approximately half the
ases of intrauterine growth retardation (Gerretsen et al.,
981) are associated with abnormally shallow cytotropho-
last invasion. Conversely, invasion that is overly exten-
ive can result in both benign and malignant trophoblast
umors (Berkowitz and Goldstein, 1996).
Control of cytotrophoblast invasion requires the develop-
ental regulation of several classes of molecules, including
hose involved in adhesion and proteolysis. Normally, the
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195IL-10 Regulates Trophoblast MMP-9 Activity and Invasionexpression of cell–cell (e.g., cadherins, Ig superfamily) and
cell–extracellular matrix (ECM) (e.g., integrin receptors)
adhesion molecules is extensively modulated as cytotro-
phoblasts invade the uterine wall (Fisher et al., 1989; Aplin,
991; Damsky et al., 1992). In preeclampsia, where placen-
tation is shallow, differentiating/invading cytotrophoblasts
fail to correctly modulate members of all three adhesion
molecule families (Zhou et al., 1993, 1997; Lim et al., 1997).
With regard to proteinases, human cytotrophoblasts pro-
duce both the urokinase-type plasminogen activator
(Queenan et al., 1987) and matrix metalloproteinase-9
(MMP-9; Fisher et al., 1989). Although the urokinase-type
plasminogen activator does not appear to directly mediate
cytotrophoblast invasion in vitro, MMP-9 activity is abso-
lutely required for cytotrophoblast degradation of and inva-
sion through Matrigel (Librach et al., 1991). As with the
adhesion molecules that are critical to invasion, MMP-9
expression is misregulated in preeclampsia (Lim et al.,
1997).
MMPs are a family of ECM-degrading enzymes that share
common structural domains (reviewed in Matrisian, 1990;
Sang and Douglas, 1996). These proteinases are secreted as
inactive zymogens and are activated by proteolytic cleav-
age. MMPs require Ca21 binding for structural integrity and
n21 for catalysis. Consequently, their activity can be
nhibited by chelating agents in vitro (Murphy and Do-
herty, 1992). In vivo, MMP induction in areas of matrix
emodeling is under the tight control of several regulatory
echanisms. Proteinase abundance is regulated at the tran-
criptional level, as well as posttranscriptionally, by
hanges in mRNA stability. After secretion, MMP enzy-
atic activity is controlled by interactions with proteolytic
ctivators (e.g., membrane-type MMP) and inhibitors (e.g.,
issue inhibitors of metalloproteinases or TIMPs). This high
egree of regulation may reflect the important roles MMPs
lay in normal tissue remodeling processes such as organo-
enesis and ovulation. The abundance and activity of fam-
ly members is also increased in a variety of pathological
rocesses such as inflammation and tumor metastasis (Ries
nd Petrides, 1995).
Cytokines and growth factors involved in the regulation
f these normal and pathological events have been shown to
odulate MMP expression and proteolytic activity
Birkedal-Hansen, 1993; Ries and Petrides, 1995). Interleu-
in (IL)-1b upregulates MMP-9 production in chondrocytes
Ogata et al., 1992), synovial fibroblasts (Unemori et al.,
1991), and keratinocytes (Lyons et al., 1993). Transforming
growth factor-b also increases MMP-9 activity in keratino-
ytes (Salo et al., 1991), and in monocytes as well (Wahl et
al., 1993). Tumor necrosis factor-a upregulates MMP-9 in
both monocytes (Watanabe et al., 1993) and cervical fibro-
lasts (Sato et al., 1996), whereas epidermal growth factor
nd transforming growth factor-a upregulate keratinocyte
MMP-9 (Lyons et al., 1993). The localized secretion of
roinflammatory cytokines can thus lead to tissue destruc-
ion in disorders such as rheumatoid arthritis and periodon-
al disease (Ries and Petrides, 1995). Among the cytokines
Copyright © 1999 by Academic Press. All righthat act to downregulate proteinase activity, both IL-4
Lacraz et al., 1992) and IL-10 (Lacraz et al., 1995; Mertz et
l., 1994) have been shown to inhibit MMP-9 production in
onocytes and macrophages. Thus, cytokines play an im-
ortant role in the control of MMP-9 activity in a variety of
ell types.
Several of these cytokines and growth factors are also
ound at the maternal–fetal interface, making them likely
andidates for regulating cytotrophoblast MMP-9 expres-
ion and/or activity. We have previously reported that
uman cytotrophoblasts produce IL-1b in culture and that
his cytokine is an autocrine stimulator of MMP-9 secre-
ion and invasion (Librach et al., 1994). We hypothesized
hat the highly aggressive, yet precisely regulated nature of
ytotrophoblast invasion was evidence that the cells had
nalogous mechanisms for inhibiting MMP activity. Of the
ytokines known to downregulate MMP-9 in other cell
ypes, we recently showed that IL-10 is spontaneously
roduced in substantial quantities by human cytotropho-
lasts in vitro (Roth et al., 1996). IL-10 in cytotrophoblast
onditioned medium can inhibit an allogeneic immune
eaction, which suggests that IL-10 may be important in
rotecting the fetus from a potentially deleterious maternal
mmune response in vivo. IL-10 production is significantly
ownregulated after 12 h in culture, at the time when
ytotrophoblasts upregulate MMP-9 and differentiate into
nvasive cells. Because the secretion patterns of IL-10 and
MP-9 are inversely related, we undertook the present
tudy to determine whether IL-10 is involved in the control
f cytotrophoblast MMP-9 production and, consequently,
nvasion.
MATERIALS AND METHODS
Cell Isolation and Culture
Cytotrophoblasts were isolated by published methods from
first-, second- (Fisher et al., 1989; Librach et al., 1991), and
hird-trimester (Kliman et al., 1986) human placentas. In all cases,
ontaminating leukocytes were removed by using an antibody to
D-45, a protein tyrosine phosphatase found on bone marrow-
erived cells (Charbonneau et al., 1988), coupled to magnetic
eads. Cytotrophoblast populations prepared in this way are 95–
9% free of nontrophoblast cells as shown by the absence of
lassical HLA class I antigens (Kovats et al., 1990). Cytotropho-
lasts (1 3 106) were cultured in 1 ml serum-free medium [DME
-21 containing 2% Nutridoma (Boehringer-Mannheim)] in
6-mm culture wells precoated with a basement membrane sub-
trate (Matrigel; Collaborative Research Inc., Bedford, MA) diluted
:1 in serum-free medium as described (Librach et al., 1991). Where
pecified, 1–100 ng/ml of recombinant IL-10 (rIL-10; R & D
ystems), 1–100 mg/ml of a rat neutralizing monoclonal antibody
(mAb) (IgG2a) to IL-10 [anti-IL-10; 19F1(Bejarano et al., 1992; Gastl
et al., 1993)], or 1–100 mg/ml of a rat IgG2a isotype control (IgG;
GL117, anti-Escherichia coli b-galactosidase) was added to the
cytotrophoblast culture medium. Medium containing these addi-
tives was replaced every 24 h.Placental fibroblasts were isolated from first-trimester placentas
and cultured as previously described (Fisher et al., 1989). Peripheral
s of reproduction in any form reserved.
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196 Roth and Fisherblood leukocytes were prepared by centrifugation of blood from
normal donors on a Ficoll–Hypaque 1077 (Sigma) density gradient
according to the manufacturer’s recommendation. The leukocytes
were cultured in RPMI 1640 supplemented with 10% (v/v) heat-
inactivated human AB serum at a density of 1 3 106 cells/ml of
culture medium.
U937 cells were maintained in RPMI 1640 supplemented with
10% (v/v) fetal calf serum. To induce differentiation and MMP-9
secretion, control cells were cultured at a concentration of 1 3
106/ml in RPMI containing 50 ng/ml phorbol 12-myristate 13-
cetate (Sigma) and 0.2% lactalbumin hydrolysate (Gibco BRL). As
escribed under Results, 10 ng/ml rIL-10, 10 mg/ml 19F1, or 10
mg/ml control IgG was added to the cultures, and medium contain-
ing these additives was replaced daily.
Reverse-Transcriptase Polymerase Chain Reaction
(RT-PCR) for Detection of IL-10 Receptor mRNA
Total RNA was isolated from 106 cells by using RNAzol B
(Biotecx Laboratories, Inc., Houston, TX) according to the manu-
facturer’s recommendations. RNA was reverse transcribed by using
murine Moloney leukemia virus reverse transcriptase (Gibco BRL)
and random hexamer primers (Sigma) as previously described
(Reiner et al., 1993). PCR was performed using primers for either
the constitutively expressed housekeeping gene, hypoxanthine-
guanine phosphoribosyltransferase (HPRT), as a control for RNA
integrity or the IL-10 receptor. The following primer sets were
used: HPRT forward primer, 59-CCTGCTGGATTACATCAAAG-
CACTG-39; HPRT reverse primer, 59-TCCAACACTTCGT-
GGGGTCCT-39; IL-10 receptor forward primer, 59-AAA-
ACTTCAGCCTCCTAACCTCTGG-39 and Il-10 receptor reverse
primer, 59-CGGGTGGATGGTGTCTTGGGTCTCT-39. Amplifi-
cation products (HPRT, 288 bp; IL-10 receptor, 317 bp) were
visualized by electrophoresis on 3% ethidium bromide-stained
agarose gels and photographed.
Immunoblotting
Cytotrophoblasts were cultured for 72 h as described. Condi-
tioned medium (CM) was collected and centrifuged at 300g for 10
min and then stored at 280°C until analysis by immunoblotting,
zymography, or a soluble assay of metalloproteinase activity (de-
scribed below). For immunoblot analysis, CM [75% (v/v)] was
solubilized in loading buffer, subjected to sodium dodecyl sulfate–
polyacrylamide gel electrophoresis (SDS–PAGE), and transferred by
blotting to nitrocellulose as described (Librach et al., 1991). Non-
specific reactivity was blocked by incubating the blots for 1 h at
25°C in phosphate-buffered saline (PBS) containing 0.05% Tween
20 (T-PBS) and 5% nonfat dried milk (Carnation). The nitrocellu-
lose blots were then incubated for 2 h at 25°C with 5 mg/ml
anti-MMP-9 antibody (7-11C; Oncogene Research Products, Cam-
bridge, MA) suspended in T-PBS containing 5% nonfat dry milk.
The blots were washed six times (10 min each time) in T-PBS and
then incubated for 1 h at 25°C with horseradish peroxidase-
conjugated rabbit anti-mouse IgG (Jackson Immunoresearch) di-
luted 1:3000 in T-PBS containing 5% nonfat dry milk. Blots were
then washed six times (10 min each time) in T-PBS and rinsed once
in PBS. An enhanced chemiluminescence system (Amersham
Corp.) was used to detect antigen–antibody complexes, and the blot
was exposed to film.
Copyright © 1999 by Academic Press. All rightNorthern Hybridization
Total RNA (10 mg) was separated by formaldehyde–agarose gel
lectrophoresis and transferred to Nytran membranes (Schleicher
nd Schuell, Keene, NH). In all experiments, gels were stained with
cridine orange before transfer to ensure integrity of the RNA
amples and to confirm that equal amounts of RNA had been
oaded onto each lane. A TIMP-3-specific cDNA probe was synthe-
ized by random priming of a 515-bp fragment of the cDNA
nucleotides 369–884 (Silbiger et al., 1994)]. An MMP-9-specific
robe was synthesized by PCR amplification of U937 cell cDNA to
enerate a 382-bp fragment [nucleotides 15–397 (Wilhelm et al.,
989)]. Nytran membranes were analyzed by Northern blot hybrid-
zation as previously described (McMaster et al., 1995).
Substrate Gel Zymography
Cytotrophoblast or U937 cell CM [75% (v/v)] was solubilized in
nonreducing sample buffer and separated by SDS–PAGE, using
10% acrylamide gels containing 5 mg/ml gelatin (Sigma). After
electrophoresis, proteins were renatured by incubating the gel in 50
mM Tris–HCl, pH 7.6, containing 2.5% Triton X-100 for 1 h at
25°C to remove SDS. Metalloproteinases were then activated by
incubating the gel overnight at 37°C in 50 mM Tris–HCl, pH 7.8,
containing 150 mM NaCl and 5 mM CaCl2. To visualize proteinase
activity, the gel was stained with Coomassie blue. Clear bands
corresponded to areas where gelatin digestion took place. The gels
were dried onto filter supports and photographed.
Soluble Assay of Metalloproteinase Activity
Metalloproteinase activity in cytotrophoblast CM was measured
using the thiopeptolide substrate Ac-Pro-Leu-Gly-SCH[CH2-
CH(CH3)2]CO-Leu-Gly-OC2H5 (Bachem, Philadelphia, PA) in a
pectrophotometric assay (Weingarten et al., 1985). CM [25% (v/v)]
as added to a reaction mixture containing 40 mM thiopeptolide
nd 800 mM chromophore 4,49-dithiodipyridine (Sigma) in 50 mM
Hepes buffer, pH 7.0, with 10 mM CaCl2. The reaction mixture was
incubated at 25°C, and absorbance (A324) was read at intervals of 5
in for 30 min. The rate of substrate degradation is a measure of
otal MMP activity. To verify that the activity measured reflected
hat of metalloproteinases, other CM samples were incubated with
mM 1,10-phenanthroline (Sigma) for 10 min at 25°C prior to
ddition of substrate. In all cases, this abolished the observed
ctivity.
Invasion Assay
To quantify cytotrophoblast invasion, Transwell polycarbonate
filter inserts (6.5 mm; Costar) with 8-mm pores were coated with 10
ml Matrigel, and second-trimester cells (2.5 3 105 cells/250 ml
serum-free medium) were plated on top of each filter. Where
specified, 10 ng/ml rIL-10, 10 mg/ml 19F1, or 10 mg/ml control IgG
was added to the culture medium both above and below filter
inserts and replaced every 24 h. At 60 or 72 h, filters were rinsed
with PBS and the cells were fixed in 3% paraformaldehyde for 1 h
at 25°C. After three 10-min washes in PBS, cell membranes were
permeabilized with methanol for 5 min at 220°C. The filters were
washed in PBS and then incubated in PBS containing 1% bovine
serum albumin (PBS–BSA) for 1 h at 25°C to block nonspecific
antibody reactivity. Cytotrophoblasts were exposed to an antibody
to cytokeratin [1:100 (v/v) in PBS–BSA; 7D3 (Fisher et al., 1989)] for
s of reproduction in any form reserved.
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197IL-10 Regulates Trophoblast MMP-9 Activity and Invasion2 h at 25°C and then washed thoroughly with PBS. To detect
cytotrophoblast cell bodies and processes, the filters were incu-
bated with a rhodamine-conjugated anti-rat IgG [1:2000 (v/v) in
PBS–BSA; Jackson Immunoresearch] for 1 h at 25°C and then
washed again in PBS. Each of triplicate filters was cut from the
Transwell inserts with a scalpel and mounted on a slide with the
underside of the filter facing up. Cell bodies and processes that had
migrated through the filter pores and had reached the underside
were visualized by fluorescence microscopy, counted, and then
photographed.
Statistical Analyses
The statistical significance of the data was analyzed by using
analysis of variance (ANOVA) followed by pairwise comparison
using Fisher’s PLSD. The significance level was set at P , 0.05 for
ifferences from control.
RESULTS
Human Cytotrophoblasts Express IL-10 Receptor
mRNA
Our recent findings that cytotrophoblasts secrete sub-
stantial amounts of IL-10 in vitro and that production
atterns of IL-10 and MMP-9 are inversely related (Roth et
l., 1996) suggested that IL-10 may function as an autocrine
egulator of cytotrophoblast MMP-9 expression and inva-
ive activity. We began to test this hypothesis by using
T-PCR to determine whether cytotrophoblasts express the
L-10 receptor and thus have the potential to respond to the
L-10 they produce. Amplification of HPRT cDNA verified
NA integrity in each of the samples (Fig. 1). As positive
nd negative controls, cDNA for the IL-10 receptor was
mplified from peripheral blood leukocytes and placental
broblasts, respectively. After culture for 12 h, cytotropho-
lasts of all gestational ages expressed IL-10 receptor
RNA (Fig. 1).
IL-10 Downregulates Cytotrophoblast MMP-9
Secretion in Vitro
Next, we investigated whether maintaining cytotropho-
blasts in high levels of IL-10 after endogenous cytokine
secretion has ceased affects their MMP-9 secretion. In these
experiments, the cells were plated in medium that con-
tained 10 ng/ml rIL-10, and this medium was replaced every
24 h. Cytotrophoblasts were also incubated in medium that
contained 10 mg/ml of either a function-perturbing anti-
L-10 mAb or an irrelevant mAb (IgG) of the same isotype.
ontrol cells were cultured in medium alone. The amount
f MMP-9 in the conditioned medium of the variously
reated cells was estimated at 24, 48, and 72 h by immuno-
lotting. Figure 2A shows the results of a typical experi-
ent. The effects of cytokine and anti-IL-10 treatment
ecame more pronounced over time. By 72 h, we consis-
ently found that cytotrophoblasts cultured in rIL-10 se-
reted significantly less MMP-9 than cells incubated in
Copyright © 1999 by Academic Press. All rightedium alone. Conversely, cytotrophoblasts incubated in
nti-IL-10 secreted significantly more MMP-9 than control
ells, whereas adding an irrelevant IgG to the medium had
o effect. Figure 2B summarizes the results of five different
xperiments in which we analyzed, by immunoblotting, the
ffects of these various treatments on cytotrophoblast
MP-9 secretion. Compared with the controls (medium
lone, irrelevant IgG), adding rIL-10 decreased cytotropho-
last MMP-9 secretion to 41 6 10% of control levels (P ,
0.05), whereas anti-IL-10 treatment increased MMP-9 levels
to 119 6 7% (P , 0.05).
We then determined, by immunoblotting, whether the
cytokine and antibody effects we observed after 72 h of
culture were dose dependent. Figure 3 shows the results of
a typical experiment. The addition of 1–100 ng/ml rIL-10 to
cultured cytotrophoblasts resulted in a dose-dependent in-
hibition of MMP-9 secretion; the lowest dose had no effect
and the highest dose had the greatest effect. Conversely,
1–100 mg/ml of anti-IL-10 resulted in a dose-dependent
ncrease in MMP secretion. As expected, cells treated with
–100 mg/ml of an irrelevant IgG secreted the same amount
f MMP-9 as control cytotrophoblasts incubated in medium
lone. Together, the data in Figs. 2 and 3 demonstrate that
L-10 is an autocrine inhibitor of cytotrophoblast MMP-9
roduction in vitro.
IL-10 Downregulates MMP-9 Production at a
Pretranslational Level, but Does Not Affect
TIMP-3 mRNA Expression
FIG. 1. Human cytotrophoblasts express IL-10 receptor mRNA in
vitro. RNA was extracted from peripheral blood leukocytes (PBL),
first- and second-trimester (TM) and term placental cytotropho-
blasts, and first-trimester placental fibroblasts (PFib) and reverse
transcribed. The cDNA for HPRT or the IL-10 receptor (IL-10R) was
amplified by PCR. The products (and a standard 1-kb DNA ladder)
were separated by electrophoresis in agarose gels, visualized by
ethidium bromide staining, and photographed. Amplification with
the HPRT primer set produces a 288-base-pair PCR product, while
IL-10 receptor primers amplify a 317-base-pair fragment. RNA
integrity was assured by the amplification of HPRT in all samples.To better understand the regulatory mechanisms in-
volved, we determined whether the addition of exogenous
s of reproduction in any form reserved.
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198 Roth and FisherIL-10 to cytotrophoblasts affects their levels of MMP-9
mRNA. Three different preparations of cells were cultured
in medium alone (control) or in medium containing 10
ng/ml rIL-10, 10 mg/ml anti-IL-10 mAb, or 10 mg/ml of an
rrelevant mAb (IgG). Medium containing these additives
as replaced daily, and total RNA was extracted after 36
nd 72 h. The RNA samples from each cell preparation were
ooled, and MMP-9 mRNA levels were assessed by North-
rn blot hybridization (Fig. 4). In accord with the regulation
e observed at the protein level, rIL-10 treatment decreased
MP-9 mRNA levels, whereas anti-IL-10 treatment in-
reased them, and the observed effects became more pro-
ounced over time. Normalized for RNA loading differ-
nces, densitometric analysis showed that exposing
ytotrophoblasts to rIL-10 for 36 and 72 h caused 15 and
0% decreases in MMP-9 mRNA levels, respectively. Con-
ersely, exposing cytotrophoblasts to anti-IL-10 for 36 and
FIG. 2. Cytotrophoblast IL-10 is a negative regulator of MMP-
indicated times in culture medium alone (C), 10 ng/ml recombi
(anti-IL-10), or 10 mg/ml of an isotype-matched irrelevant antibody
sing an antibody specific for MMP-9. (B) The relative intensities
ensitometric analysis. Data are expressed as percentages of contro
nalysis of variance (ANOVA) followed by pairwise comparison.
FIG. 3. The effect of IL-10 on MMP-9 secretion is dose dependent.
Second-trimester cytotrophoblasts were cultured in culture me-
dium alone (C) or with decreasing concentrations of rIL-10 (100–19 secretion. Second-trimester cytotrophoblasts were cultured for the
nant IL-10 (rIL-10), 10 mg/ml of a function-perturbing mAb to IL-10
(IgG). (A) Conditioned media (CM) were analyzed by immunoblotting
of MMP-9 bands from five experiments were measured after 72 h byng/ml), anti-IL-10 (100–1 mg/ml), or IgG (100–1 mg/ml). CM were
ollected after 72 h in culture and analyzed by immunoblotting.
T
s
Copyright © 1999 by Academic Press. All rightFIG. 4. IL-10 downregulates cytotrophoblast MMP-9 mRNA ex-
pression, but does not affect TIMP-3 mRNA levels. Second-
trimester cytotrophoblasts were cultured in medium alone (C), 10
ng/ml rIL-10, 10 mg/ml anti-IL-10, or 10 mg/ml IgG. Total RNA was
xtracted from cytotrophoblasts after 36 and 72 h in culture. RNA
rom three different preparations of cells was pooled and subjected
o Northern hybridization using a cDNA probe for MMP-9, which
ybridized to a single 2.4-kb transcript. This blot was then stripped
nd probed for TIMP-3 as described under Materials and Methods.
he TIMP-3 probe hybridized to multiple cytotrophoblast tran-
cripts, 1.1, 2.4, 2.7, and 4.4 kb in size.
s of reproduction in any form reserved.
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199IL-10 Regulates Trophoblast MMP-9 Activity and Invasion72 h caused 16 and 46% increases in MMP-9 mRNA levels,
respectively. MMP-9 mRNA levels in cells treated for the
same length of time with an irrelevant IgG were no differ-
ent from those of control cells (Fig. 4). These results suggest
that IL-10 can regulate cytotrophoblast MMP-9 production
at the pretranslational level.
We were also interested in whether IL-10 has similar
effects on MMP-9 mRNA in other cell types. We chose to
study U937 cells, a line of human mononuclear phagocytes
that produce MMP-9 (Morodomi et al., 1992) and express
the IL-10 receptor (Takeshita et al., 1996). U937 cells were
cultured in medium alone (control) or in medium contain-
ing 10 ng/ml rIL-10, 10 mg/ml anti-IL-10 mAb, or 10 mg/ml
of an irrelevant IgG for 72 h. Northern blot hybridization
showed that neither IL-10 nor antibody treatment signifi-
cantly affected MMP-9 mRNA levels (data not shown). This
was in contrast to previous studies showing that the same
amount of IL-10 downregulates MMP-9 production by pri-
mary monocytes and macrophages (Lacraz et al., 1995).
Taken together, our results and those of other investigators
suggest that the effects of IL-10 on MMP-9 production are
cell type specific.
Next, we determined whether IL-10 regulates cytotropho-
blast TIMP production. These cells make very little TIMP-1
and -2. However, expression of TIMP-3 protein and mRNA,
as that of MMP-9, is dramatically upregulated in the first
12 h in culture (Bass et al., 1997). Since TIMP-3 can inhibit
MMP-9 activity (Apte et al., 1995), changes in its levels
could affect cytotrophoblast proteolytic capacity. To deter-
mine whether IL-10 regulates cytotrophoblast TIMP-3
mRNA expression, the filter shown in Fig. 4 was stripped
FIG. 5. Cytotrophoblast IL-10 is a negative regulator of MMP-9
medium alone (C), 10 ng/ml rIL-10, 10 mg/ml anti-IL-10, or 10 mg
described under Materials and Methods. (A) Bands show areas of ge
were measured by densitometric analysis. Data are expressed as perc
with control by analysis of variance (ANOVA) followed by pairwisand hybridized with a TIMP-3-specific probe. When nor-
malized for differences in RNA loading, densitometric
Copyright © 1999 by Academic Press. All rightnalysis showed that neither IL-10 nor anti-IL-10 treatment
or 72 h changed TIMP-3 mRNA levels. These data suggest
hat IL-10 changes the MMP/TIMP balance in favor of the
nhibitor. As a consequence, net cytotrophoblast MMP
ctivity should decrease.
IL-10 Downregulates Cytotrophoblast MMP-9
Activity
We used two methods to assess the effects of IL-10 on
cytotrophoblast MMP activity, beginning with zymography
for an initial estimate of changes. Consistent with our
previous observations (Fisher et al., 1989; Librach et al.,
1991), the major gelatinolytic activity was in the 92-kDa
region, and none of the cytokine or antibody treatments
induced other activities (data not shown). The effects of
rIL-10 and anti-IL-10 on cytotrophoblast MMP-9 activity
paralleled their effects on MMP-9 protein expression, as
shown by immunoblotting (Fig. 2A). Again, these changes
were somewhat variable during the first 2 days of culture
(data not shown), but at 72 h we found consistent differ-
ences. Figure 5A shows the results of a typical experiment.
Cytotrophoblasts cultured in rIL-10 secreted considerably
less 92-kDa gelatinolytic activity than control cells, and
cytotrophoblasts incubated in anti-IL-10 secreted consider-
ably more 92-kDa gelatinolytic activity. Figure 5B summa-
rizes the results of five experiments. After cytokine treat-
ment for 72 h, MMP-9 activity declined to 62 6 9% of
control levels (P , 0.05), whereas anti-IL-10 treatment
caused MMP-9 activity to increase by 48 6 12% (P , 0.05).
Addition of the control, isotype-matched IgG did not affect
vity. Second-trimester cytotrophoblasts were cultured in culture
gG. CM was collected after 72 h and analyzed by zymography as
olysis. (B) The relative intensities of bands from five experiments
ges of control. Values represent means 6 SEM; *P , 0.05 compared
mparison.acti
/ml I
latingelatin degradation. Finally, these effects on cytotropho-
blast MMP-9 activity depended on the dose of IL-10 or
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200 Roth and Fisheranti-IL-10 that was added to the cells. Figure 6 shows
results typical of the three experiments we performed. The
addition of 1–100 ng/ml rIL-10 to cultured cytotrophoblasts
resulted in a dose-dependent inhibition of MMP-9 gelatino-
lytic activity; the lowest dose had no effect and the higher
doses had the greatest effects. Conversely, 1–100 mg/ml
nti-IL-10 resulted in a dose-dependent increase in MMP
elatinolytic activity. Again, the control IgG had no effect.
Because zymography is not rigorously quantitative, we
lso used a very sensitive chromogenic assay to quantify the
ffects of IL-10 and anti-IL-10 on cytotrophoblast MMP
ctivity (Weingarten et al., 1985). Figure 7 shows the results
f five such experiments. After 72 h in culture, control
onditioned medium and medium that contained an irrel-
vant IgG contained the same levels of MMP activity. As
redicted from the zymogram data, rIL-10 treatment re-
ulted in a 33 6 9.7% decrease in MMP activity from
ontrol levels (P , 0.05). Conversely, anti-IL-10 stimulated
MP activity by 43 6 15% (P , 0.05). Together, the results
f the zymogram and chromogenic assays suggest that IL-10
s a negative regulator of cytotrophoblast MMP-9 activity.
IL-10 Inhibits Cytotrophoblast Invasive Capacity
in Vitro
Our lab has shown that cytotrophoblast MMP-9 activity
is required for one of the cells’ most important and unusual
functions, namely invasion (Librach et al., 1991). To test
he functional relevance of IL-10 regulation of MMP-9
xpression and activity, we quantified the invasive capacity
f cytotrophoblasts treated with cytokine, anti-IL-10, or
ontrol IgG in vitro. Specifically, we assayed the cells’
bility to invade Matrigel-coated, porous polycarbonate
lters. Initially, the cells send long processes through the
lter pores (48–72 h). Soon thereafter, entire cell bodies
merge on the filter underside (72 h onward).
Figure 8A summarizes the results of three experiments in
hich we assayed the effects of IL-10 on the appearance of
ytotrophoblast cell processes on the bottom of the filter.
FIG. 6. The effect of IL-10 on MMP-9 activity is dose dependent.
econd-trimester cytotrophoblasts were cultured in culture me-
ium alone (C) or with decreasing concentrations of rIL-10 (100–1
g/ml), anti-IL-10 (100–1 mg/ml), or IgG (100–1 mg/ml). CM was
collected after 72 h and analyzed by zymography (see Materials and
Methods). Bands show areas of gelatinolysis.hen the cells were cultured for 60 h in the presence of
IL-10, 64 6 8% fewer cytotrophoblasts traversed the filter
0
f
Copyright © 1999 by Academic Press. All rightores compared with cells cultured in medium alone (P ,
.05). Conversely, neutralizing IL-10 function caused a 33 6
% increase in the number of cell processes that emerged
n the filter underside (anti-IL-10), whereas the irrelevant
Ab (IgG) had no effect (P , 0.05). Later in the culture
eriod, we found that these same treatments also affected
he number of cell bodies that emerged on the bottom of the
lters. After 72 h, cytokeratin staining of control cultures
nd those treated with irrelevant IgG showed that most of
he pores contained cell processes (Fig. 8B). A few cell
odies were also visible on the bottom of the filter. In the
resence of rIL-10, many fewer processes reached the pores
nd no cell bodies were visible. With anti-IL-10 treatment,
nvasion was enhanced such that many cell bodies were
resent on the filter underside. Together, these data show
hat IL-10 is an autocrine inhibitor of cytotrophoblast
nvasion in vitro.
DISCUSSION
IL-10 is a pleiotropic cytokine whose known functions
include the regulation of both immune responses and
proteinase production. Among its potent immunosuppres-
sive effects are the downregulation of proinflammatory
cytokine synthesis and the inhibition of alloreactive T-cell
proliferation (Moore et al., 1993). IL-10 has also been shown
to regulate the expression of both serine proteinases
(Ghildyal et al., 1992a,b) and matrix metalloproteinases
FIG. 7. IL-10 downregulates cytotrophoblast MMP-9 activity.
Second-trimester cytotrophoblasts were cultured in culture me-
dium alone (C) or medium containing 10 ng/ml rIL-10, 10 mg/ml
nti-IL-10, or 10 mg/ml IgG. CM was collected after 72 h and added
25% (v/v)] to a synthetic thiopeptolide MMP substrate as described
nder Materials and Methods. Hydrolysis of this substrate was
easured over 30 min. Data are expressed as percentages of
ontrol. Values represent means 6 SEM of five experiments; *P ,
.05 compared with control by analysis of variance (ANOVA)
ollowed by pairwise comparison.
s of reproduction in any form reserved.
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FIG. 8. IL-10 inhibits cytotrophoblast invasion in vitro. Second-tri
polycarbonate filter supports in culture medium alone (C) or medium
Materials and Methods). (A) Some cultures were fixed after 60 h an
underside were counted. Data are expressed as percentages of contr
compared with control by analysis of variance (ANOVA) followed by p
72 h and then subjected to immunohistochemistry and photographe
experiments. Bar 5 15 mm.n a variety of cell types. Proteinase activity is required for
ytotrophoblast invasion of the uterine wall during placen-
a
c
Copyright © 1999 by Academic Press. All rightation. At the same time, these allogeneic fetal cells must
er cytotrophoblasts were cultured on top of Matrigel-coated porous
ntaining 10 ng/ml rIL-10, 10 mg/ml anti-IL-10, or 10 mg/ml IgG (see
ined with cytokeratin antibodies and cytotrophoblasts on the filter
alues represent means 6 SEM from three experiments; *P , 0.05
se comparison. (B) In other cultures, cytotrophoblasts were fixed after
e photomicrograph shown in B is typical of the results of the threemest
co
d sta
ol. Vvoid maternal immune rejection. This suggested to us that
ytotrophoblast IL-10 could play a role in the regulation of
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202 Roth and Fisherboth of these biological processes. We previously described
cytotrophoblast IL-10 synthesis in vitro and showed that
this cytokine, present in the cells’ conditioned medium,
can suppress allogeneic T-lymphocyte reactivity (Roth et
al., 1996). We now demonstrate that IL-10 acts via an
autoregulatory mechanism to specifically inhibit cytotro-
phoblast MMP-9 production at the pretranslational level.
The subsequent downregulation of proteinase secretion
results in a decrease in MMP-9 activity; as a consequence,
cytotrophoblast invasion is significantly compromised.
IL-10 thus represents an important link between placen-
tal immune protection of the fetus and cytotrophoblast
invasion of the uterus. We find that cytotrophoblast stem
cells produce IL-10 in vivo (I. Roth and D. Figueroa, unpub-
lished observations). Our data show that IL-10 is downregu-
lated as these cells differentiate, thus permitting the pro-
duction of MMP-9 necessary for uterine invasion. In the
absence of IL-10 secretion, the expression of HLA-G by
invasive cytotrophoblasts in the uterine wall may protect
these cells from maternal immune attack (Kovats et al.,
1990; McMaster et al., 1995; Pazmany et al., 1996). How-
ver, if invading cytotrophoblasts encounter an immuno-
ogically hostile environment, IL-10 production could be
pregulated to serve two important functions: high cyto-
ine levels will suppress a harmful immune reaction, and
nvasion will be restricted to minimize the number of
ytotrophoblasts in contact with maternal leukocytes. In
upport of this hypothesis, preliminary observations sug-
est that IL-10 levels are markedly elevated in severe
reeclampsia in vivo (I. Roth and S. Fisher, unpublished
observations). This disorder is believed to have an immu-
nological basis and is characterized by abnormally shallow
cytotrophoblast invasion of the uterine wall (Friedman et
al., 1991).
Here we demonstrate that cytotrophoblast IL-10 acts via
an autocrine mechanism to downregulate MMP-9 secretion
without affecting TIMP-3 mRNA expression. Cytokine
treatment thus increases the effective ratio of inhibitor-to-
proteinase levels, resulting in a net decrease in proteolytic
activity and invasion. Hence, the consequences of suppress-
ing proteinase production alone are amplified. These obser-
vations suggest that cytotrophoblast expression of MMP
and TIMP mRNAs is regulated by disparate mechanisms. A
similar phenomenon has been described in monocytes and
macrophages. In these cells, treatment with interferon-g
(Shapiro et al., 1990), IL-4 (Lacraz et al., 1992), or IL-10
(Lacraz et al., 1995) has different effects on expression of
MP and TIMP mRNA. For example, IL-10 downregulates
onocyte/macrophage MMP-9 mRNA but stimulates
IMP-1 expression (Lacraz et al., 1995). Together, these
findings highlight the complex, cell-type-specific nature of
cytokine regulation of ECM degradation.
Finally, cytotrophoblast invasion of the uterine wall is
one of the critical first steps for successful human preg-
nancy. Because of its importance, this process is undoubt-
edly influenced by many redundant regulatory mecha-
nisms. We have identified several molecular targets for both
Copyright © 1999 by Academic Press. All righthe spatial and temporal control of cytotrophoblast inva-
ion (Damsky et al., 1993; Cross et al., 1994). In addition to
MMP-9, cytotrophoblast expression of adhesion molecules,
including integrins, cadherins, and Ig superfamily mem-
bers, is modulated in normal pregnancy (Damsky et al.,
1993; Zhou et al., 1997). We have also shown that adhesion
olecule expression is disregulated in preeclampsia, in
hich cytotrophoblast invasion is shallow (Zhou et al.,
993, 1997). Thus, the interesting possibility exists that
L-10 also affects the production of these important mol-
cules.
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